Numerion Labs
ActiveAI-nativeArtificial intelligence for drug discovery.
What it does
Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms. The company unites computational chemistry, structural biology, and medicinal chemistry to pioneer the next generation of AI-driven drug discovery platforms.
Its site says now · captured 2026-08-23
Innovative Approaches in Drug Discovery Using Machine Learning
Our AI superplatform explores chemical space for novel molecules, enhancing drug discovery using machine learning to uncover unseen potential.
Next to it in Healthcare and bio · AI-powered drug discovery platform
- Synkrino BiotherapeuticsY Combinator S18
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
- CardiaTec BiosciencesPlug and Play
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
- OwkinPlug and Play
Owkin combines life-science and machine learning expertise to make drug development and clinical trial design more targeted and more cost effective. Owkin's machine learning algorithms create models that predict disease evolution and treatment outcomes.
- RevorfPlug and Play
Revorf is a medical technology and drug discovery platform.
- SOCIUM IncPlug and Play
SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules.
- Pragma Bio (former VastBiome)Plug and Play
Mining the microbiome for novel products with therapeutic effect
- PerlaraY Combinator W16
Perlara: building the YC for rare disease parents
- モジュラス株式会社Plug and Play
Modulus Discovery is a preclinical-stage technology-driven drug discovery firm.